The Tick Saliva Peptide HIDfsin2 TLR4-Dependently Inhibits the Tick-Borne Severe Fever with Thrombocytopenia Syndrome Virus in Mouse Macrophages

Luyao Wang,Yishuo Liu,Rui Pang,Yiyuan Guo,Yingying Ren,Yingliang Wu,Zhijian Cao
DOI: https://doi.org/10.3390/antibiotics13050449
2024-05-16
Antibiotics
Abstract:Ticks transmit a variety of pathogens to their hosts by feeding on blood. The interactions and struggle between tick pathogens and hosts have evolved bilaterally. The components of tick saliva can directly or indirectly trigger host biological responses in a manner that promotes pathogen transmission; however, host cells continuously develop strategies to combat pathogen infection and transmission. Moreover, it is still unknown how host cells develop their defense strategies against tick-borne viruses during tick sucking. Here, we found that the tick saliva peptide HIDfsin2 enhanced the antiviral innate immunity of mouse macrophages by activating the Toll-like receptor 4 (TLR4) signaling pathway, thereby restricting tick-borne severe fever with thrombocytopenia syndrome virus (SFTSV) replication. HIDfsin2 was identified to interact with lipopolysaccharide (LPS), a ligand of TLR4, and then depolymerize LPS micelles into smaller particles, effectively enhancing the activation of the nuclear factor kappa-B (NF-κB) and type I interferon (IFN-I) signaling pathways, which are downstream of TLR4. Expectedly, TLR4 knockout completely eliminated the promotion effect of HIDfsin2 on NF-κB and type I interferon activation. Moreover, HIDfsin2 enhanced SFTSV replication in TLR4-knockout mouse macrophages, which is consistent with our recent report that HIDfsin2 hijacked p38 mitogen-activated protein kinase (MAPK) to promote the replication of tick-borne SFTSV in A549 and Huh7 cells (human cell lines) with low expression of TLR4. Together, these results provide new insights into the innate immune mechanism of host cells following tick bites. Our study also shows a rare molecular event relating to the mutual antagonism between tick-borne SFTSV and host cells mediated by the tick saliva peptide HIDfsin2 at the tick–host–virus interface.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how tick salivary peptide HIDfsin2 enhances the antiviral innate immune response of mouse macrophages by activating the Toll - like receptor 4 (TLR4) signaling pathway, thereby inhibiting the replication of severe fever with thrombocytopenia syndrome virus (SFTSV) transmitted by ticks. Specifically, the study aims to reveal the interaction between HIDfsin2 and lipopolysaccharide (LPS), and break it down into smaller particles, effectively enhancing the activation mechanisms of nuclear factor - κB (NF - κB) and type I interferon (IFN - I) signaling pathways, which are located downstream of TLR4. In addition, the study also explores the effect of HIDfsin2 on SFTSV replication in TLR4 - knockout mouse macrophages, and how HIDfsin2 promotes SFTSV replication in human cell lines A549 and Huh7 with low TLR4 expression by hijacking p38 mitogen - activated protein kinase (MAPK). Through this series of studies, the authors hope to provide new insights into how host cells develop defense strategies against tick - borne viruses after tick bites, and reveal the molecular events mediated by HIDfsin2 in the mutual antagonism at the tick - host - virus interface.